GlassScriptPhysician profile
Alexander Joseph Jones
NPI 1962065631
$1,200.52
in general payments reported to CMS, 2019-2025
10 companies · $709 in 2025
The $709 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $59.49 · 2024: $432 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $405.25 | 2024-2025 | Na, Vsp System, Vsp Cranial, Core |
| Aroa Biosurgery Incorporated | $145.76 | 2025 | |
| Ambu INC. | $123.74 | 2025 | |
| Integra Lifesciences Corporation | $110.12 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Avita Medical Americas, LLC | $108.37 | 2024 | |
| Depuy Synthes Sales INC. | $106.92 | 2024 | Trumatch, Matrixmandible |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.83 | 2023-2024 | Jardiance |
| Coopersurgical, INC. | $69.38 | 2025 | Onetrac Lx |
| Daiichi Sankyo INC. | $28.81 | 2023 | Injectafer |
| Humacyte Global, INC. | $26.34 | 2025 | Symvess |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.